MBX Biosciences (MBX) Shares Issued (2023 - 2026)

MBX Biosciences (MBX) has 4 years of Shares Issued data on file, last reported at $4.7 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Issued rose 96.86% year-over-year to $4.7 million; the trailing twelve-month figure through Mar 2026 stood at $4.7 million (up 96.86% YoY), and the FY2025 full-year result was $4.6 million, up 30.15% from the prior year.
• Shares Issued advanced to $4.7 million in Q1 2026, from $4.6 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $4.7 million in Q1 2026 to a low of $2.3 million in Q2 2025.
• A 4-year average of $3.2 million and a median of $3.0 million in 2023 frame the typical range for Shares Issued.
• Across the five-year window, Shares Issued plunged 31.45% in 2025 and soared 96.86% in 2026, its largest moves.
• Tracing MBX's Shares Issued over 4 years: stood at $2.5 million in 2023, then surged by 40.45% to $3.5 million in 2024, then soared by 30.15% to $4.6 million in 2025, then climbed by 2.97% to $4.7 million in 2026.
• Business Quant data shows MBX's Shares Issued at $4.7 million in Q1 2026, $4.6 million in Q4 2025, and $2.4 million in Q3 2025.